商標ウォッチ

TOP｜特許｜意匠｜商標

商標ウォッチ Twitter

公開日2025-03-05
公報種別公開国際商標公報
国際登録番号1830675
国際登録日2024-10-09
区分第1類(化学品),第5類(薬剤),第40類(製造・加工),第42類(科学・技術)
商品役務Modified cells, in particular genetically modified iPS (induced pluripotent stem) cells and differentiated cells derived therefrom, for research or scientific purposes; cell cultures, cell culture systems and cryopreserved genetically modified iPS cells for scientific and industrial research purposes; cell cultures, and cryopreserved cells iPS cells other than for medical or veterinary use; compositions and materials for scientific use, including cell culture agents for use in the biotechnology industry and cell material for use in combination with human cells, including genetically modified iPS or differentiated stem cells.,Modified cells, in particular genetically modified iPS (induced pluripotent stem) cells or differentiated cells derived therefrom, for medical or veterinary use; cell cultures and cell culture systems, and cryopreserved pluripotent stem cells for medical or veterinary use; genetically modified iPS (induced pluripotent stem) cells for use in generating other cells for therapeutic purposes; cell cultures and cell culture systems, and cryopreserved genetically modified pluripotent stem cells for sub cultivation of cells.,Custom manufacturing of iPS derived cells, and iPS derived cell therapy and manufacturing processes for others, including manufacturing in GMP-based facilities; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies for others, including manufacturing in GMP-based facilities; custom manufacture of cellular therapies 全 31 件を表示, including manufacturing in GMP-based facilities; manufacturing of cell lines (modified cells with specific genetic edits) for use in generating other cells.,Research and testing of cell-based products, in particular therapeutic products; research, optimization and testing of cell production processes; laboratory research in the field of biotechnology using genetically modified iPS (induced pluripotent stem) cells or differentiated cells derived therefrom; Scientific research, design and development of scientific cell culture, cell therapy or gene edited cell therapy; Scientific research, design and development of cell culture, cell therapy or gene edited cell therapy, manufacturing systems and manufacturing processes for others; platform as a service [Paas] in the field of cell therapy, and cell therapy development; providing temporary use of a technological platform for the manufacturing of cell-based therapies, including technology, processes, and data analytics capabilities for process optimization and quality control.
基礎出願番号018984056
基礎出願日2024-02-07
基礎出願国EM
出願人Celyntra Therapeutics SA
OCRテキストぎん芝 Sき少多N 人N Allo Chassis
OCRテキスト2
OCRについて

この商標をJ-PlatPatで参照する

関連商標

Telix ARTMS Inc.

Nanjing COSMOS Chemical Co., Ltd.

Corregene Biotechnology Co., Ltd.

DONGSUNG CHEMICAL CO., LTD.

DongsungFinetec

Clover Corporation Limited

Lydian Labs, Inc.

Samyang Holdings Corporation

Sartorius Stedim North America Inc.

Hueck Folien Gesellschaft m.b.H.

Samsung Biologics Co., Ltd.

New England Biolabs, Inc.

NEBNEXTULTRAEXPRESS

Molecular Probes, Inc.

TriLink BioTechnologies, LLC

Roche Diagnostics GmbH

Life Technologies Corporation

Life Technologies Corporation

Life Technologies Corporation

Life Technologies Corporation

Westlake Corporation

Westlake Corporation

Gen-Probe Incorporated

続きを見る